PCD Pharma Franchise Opportunities in Goa with Daksh Diabetes and Cardiac Care
Recent data from the National Family Health Survey (NFHS-6) 2023-24 paints a stark picture of Goa’s deepening lifestyle disease crisis, with the state consistently outpacing national averages. The data reveals that 32.1% of men and 27.5% of women in Goa have blood sugar levels above 140mg/dl or are on diabetes medication far exceeding national averages of 20.9% for men and 17.8% for women. Goa’s 32.1% prevalence among men is the highest in the country, with the numbers rising sharply from 24.1% in NFHS-5.
The obesity epidemic is equally alarming. Nearly half of Goa’s population is now overweight or obese, with 43.6% of men and 45.1% of women having a BMI of 25.0kg/m² or above compared to national averages of 27.3% for men and 30.7% for women. Goa also leads in abdominal obesity, with 51.8% affected. The rural-urban divide is striking, with urban men showing 36.3% diabetes prevalence compared to 27.4% in rural men, and urban women recording 48.3% obesity against 41.1% in rural areas. On hypertension, 27.5% of men and 26.2% of women have elevated blood pressure, with rural women recording higher rates at 27.8%.
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Goa families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Goa
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Goa patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Goa
Daksh works with hospitals, clinics, and pharmacies across Goa to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. The pharma market in Goa offers low investment (starting at ₹25,000) with high profit margins and monopoly rights in selected areas.
Popular Locations for PCD Pharma Franchise in Goa
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Panaji | Cardiac diabetic PCD company in Panaji |
| PCD pharma franchise in Margao | Cardiac diabetic products in Margao |
| PCD pharma franchise in Vasco | Diabetic cardiac PCD franchise in Vasco |
| PCD pharma franchise in Mapusa | Cardiac diabetic PCD company in Mapusa |
| PCD pharma franchise in Ponda | Cardiac diabetic products in Ponda |
| PCD pharma franchise in Bicholim | Diabetic cardiac PCD franchise in Bicholim |
| PCD pharma franchise in Calangute | Cardiac diabetic PCD company in Calangute |
| PCD pharma franchise in Verna | Cardiac diabetic products in Verna |
| PCD pharma franchise in Curchorem | Diabetic cardiac PCD franchise in Curchorem |
| PCD pharma franchise in Canacona | Cardiac diabetic PCD company in Canacona |
Conclusion
The diabetes and heart disease epidemic in Goa is not just a statistic it is a reality affecting thousands of families. With the state recording the highest diabetes prevalence among men at 32.1% and obesity rates of over 43%, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |